ORIGINAL RESEARCH article
Front. Oncol., 30 November 2022
Sec. Gastrointestinal Cancers: Hepato Pancreatic Biliary Cancers
Volume 12 - 2022 | https://doi.org/10.3389/fonc.2022.1049345
RETRACTED: COL10A1-DDR2 axis promotes the progression of pancreatic cancer by regulating MEK/ERK signal transduction
Zhihui Wen 1,2,3†
Jingbo Sun 2†
Junjie Luo 4
Yun Fu 1
Yue Qiu 1
Yanyan Li 1
Yangwei Xu 1
Hongmei Wu 1
Qingling Zhang 1,2*
1. Department of Pathology, Guangdong Provincial People’s Hospital, Guangdong Academy of Medical Sciences, Guangzhou, Guangdong, China
2. Department of Pathology, School of Basic Medical Sciences, Southern Medical University, Guangzhou, Guangdong, China
3. Institute of Hematology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China
4. Department of General Surgery, The Third Affiliated Hospital of Southern Medical University, Guangzhou, Guangdong, China
Summary
Citation
Wen Z, Sun J, Luo J, Fu Y, Qiu Y, Li Y, Xu Y, Wu H and Zhang Q (2022) RETRACTED: COL10A1-DDR2 axis promotes the progression of pancreatic cancer by regulating MEK/ERK signal transduction. Front. Oncol. 12:1049345. doi: 10.3389/fonc.2022.1049345
Received
20 September 2022
Accepted
10 November 2022
Published
30 November 2022
Volume
12 - 2022
Edited by
Sumit Sahni, Royal North Shore Hospital, Australia
Reviewed by
Sean Porazinski, The Kinghorn Cancer Centre, Australia; Jiefeng Zhao, Second Affiliated Hospital of Nanchang University, China
Updates
†These authors have contributed equally to this work
This article was submitted to Gastrointestinal Cancers: Hepato Pancreatic Biliary Cancers, a section of the journal Frontiers in Oncology
Disclaimer
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.